Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The vaccine shouldn’t dramatically change things. Cash rich companies that are expected to grow at 40%+ would still get a premium over value companies. Companies that had good growth rates pre-covid should maintain good growth rates post-covid. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The vaccine will take time to be distributed. Investors are probably comfortable going forward, especially with the vaccine coming in time. Markets did alright even with the world completely closed. With bond returns low, bond-to-stock asset allocation shift will continue to be a big driver. Unlock Premium - Try 5i Free